Unresectable Stage III NSCLC Should Not be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection

Affiliations

• ¹ Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. Electronic address: DMoghanaki@mednet.ucla.edu.
• ² Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
• ³ Section of Interventional Pulmonology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
• ⁴ Division of Thoracic Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.